These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1038 related items for PubMed ID: 7600653

  • 21. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR.
    Med Klin (Munich); 2003 Jan 15; 98(1):1-6. PubMed ID: 12540987
    [Abstract] [Full Text] [Related]

  • 22. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
    Guazzi M, Pontone G, Trevisi N, Lomanto M, Matturri M, Agostoni P.
    Cardiologia; 1998 Feb 15; 43(2):181-7. PubMed ID: 9557374
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD.
    Circulation; 1995 Sep 15; 92(6):1499-506. PubMed ID: 7664433
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.
    Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA.
    J Card Fail; 1997 Sep 15; 3(3):173-9. PubMed ID: 9330125
    [Abstract] [Full Text] [Related]

  • 28. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP, Wei CP, Ma SC, Zhang YF, Qiao LY, Li DH, Shan RB.
    J Cardiovasc Pharmacol; 2015 May 15; 65(5):480-4. PubMed ID: 25945865
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM, Reina C, Abrignani MG, Rizzo PA, Braschi A, De Castro S.
    Am J Cardiovasc Drugs; 2006 May 15; 6(4):259-63. PubMed ID: 16913827
    [Abstract] [Full Text] [Related]

  • 32. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol.
    DasGupta P, Lahiri A.
    J Cardiovasc Pharmacol; 1992 May 15; 19 Suppl 1():S62-7. PubMed ID: 1378153
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A, COMET Investigators.
    Am Heart J; 2005 Feb 15; 149(2):370-6. PubMed ID: 15846279
    [Abstract] [Full Text] [Related]

  • 35. Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients.
    Marazzi G, Volterrani M, Caminiti G, Iaia L, Massaro R, Vitale C, Sposato B, Mercuro G, Rosano G.
    J Card Fail; 2011 Sep 15; 17(9):703-9. PubMed ID: 21872138
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
    Macdonald PS, Keogh AM, Aboyoun CL, Lund M, Amor R, McCaffrey DJ.
    J Am Coll Cardiol; 1999 Mar 15; 33(4):924-31. PubMed ID: 10091817
    [Abstract] [Full Text] [Related]

  • 38. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease.
    Lahiri A, Rodrigues EA, DasGupta P, Jain D, van der Does R, Raftery EB.
    Z Kardiol; 1989 Mar 15; 78 Suppl 3():21-7. PubMed ID: 2573213
    [Abstract] [Full Text] [Related]

  • 39. Different impact of carvedilol and transdermal scopolamine on cardiovascular performance of mild-moderate chronic heart failure patients: evidence of useful effects of scopolamine on tolerance to work load.
    De Vecchis R, Pucciarelli G, Setaro A, Nocerino L.
    Minerva Cardioangiol; 2000 Nov 15; 48(11):393-410. PubMed ID: 11214431
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.